![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Burnier Michel Pruijm Menno Wuerzner Gregoire
Publisher: Informa Healthcare
ISSN: 1742-5255
Source: Expert Opinion on Drug Metabolism and Toxicology, Vol.5, Iss.8, 2009-08, pp. : 981-987
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Calcium Channel Antagonists in the Treatment of Hypertension
By Weber M.A.
American Journal of Cardiovascular Drugs, Vol. 2, Iss. 6, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
A Review of Calcium Channel Antagonists in the Treatment of Pediatric Hypertension
Pediatric Drugs, Vol. 8, Iss. 6, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
N-type Calcium Channel Blockers: Novel Therapeutics for the Treatment of Pain
Medicinal Chemistry, Vol. 2, Iss. 5, 2006-09 ,pp. :